Publications

Rougemont-Bücking Ansgar

 List of publications (May 2020)

  • M. Hartmann, B. Schaner, K. Scheglmann, A. Bücking, R. Pfister. Hashimoto-Enzephalopathie. Steroid-sensitive Enzephalopathie bei Hashimoto-Thyreoiditis. Nervenarzt 2000 ; 71 : 489-94
  • A. Buecking, R. Pfister. Sensory ataxia as the initial clinical symptom in X-linked recessive bulbospinal neuronopathy. Journal of Neurology, Neurosurgery, and Psychiatry 2000 ; 69 : 277
  • A. Buecking, E. Rougemont, D.F Zullino. Treatment of Raynaud’s phenomenon with escitalopram. International Journal of Neuropsychopharmacology 2005 ; 8 : 307–8
  • A. Buecking, C. L. Vandeleur, Y. Khazaal, D. F. Zullino. Mirtazapine in drug-induced excessive sweating. European Journal of Clinical Pharmacology 2005; 61: 543–44
  • J. Besson, C. Eap, A. Rougemont-Buecking, O. Simon, C. Nikolov, C. Bonsack, I. Gothuey. Dépendances – acquisitions thérapeutiques 2005. Revue Médicale Suisse 2006; 2: 9–13
  • A. Rougemont-Buecking. In der Höhle des Löwen – Psychiatrische Aspekte von Neugier und Nervenkitzel. Bergundsteigen - Zeitschrift für Risikomanagement im Bergsport 2006; 2: 42-9
  • A. Rougemont-Buecking. Prendre un nouveau cap sur l’océan. EMDR et patients chroniques – quand patient et thérapeute deviennent acteurs. Santé mentale au Québec 2006; 31, 2: 277-79
  • A. Rougemont-Buecking, E. Rougemont, R. Toth, O. Simon, J. Besson. “Adrénaline-addiction” et comportements de prises de risques chez les sportifs : quelles réalités ? Revue Médicale Suisse 2007; 3: 1536-40.
  • A. Rougemont-Buecking, S. Rothen, N. Jeanprêtre, Y. Lustenberger, C. L. Vandeleur, F. Ferrero, M. Preisig. Inter-informant agreement on diagnoses and prevalence estimates of anxiety disorders: Direct interview versus family history method. Psychiatry Research, 2008; 157:211-23.
  • A. Rougemont-Bücking, M. Stankovic, G. Zimmermann, F. Borgeat, D.F. Zullino. Drug abusers suffering from social phobia show more avoidance tendencies than patients with social phobia alone. Mental Health and Substance Abuse: Dual Diagnosis, 2008; 2: 135-42.
  • E. Carruzzo, G. Zimmermann, C. Zufferey, M. Monnat, A. Rougemont-Buecking, J. Besson, J.-N. Despland. L’entretien motivationnel, une nouvelle « panacée » dans la prise en charge de patients toxicodépendants ? Une revue de littérature. Pratiques psychologiques, 2009; 15 : 405–13
  • A. Rougemont-Bücking, C. Linnman, T.A. Zeffiro, M.A. Zeidan, K. Lebron-Milad, J. Rodriguez-Romaguera, S.L. Rauch, R.K. Pitman, M.R. Milad. Altered processing of contextual information during fear extinction in PTSD: An fMRI study. CNS Neuroscience & Therapeutics, 2011 ;17 (4): 227 - 36
  • J. Besson, M. Monnat, J. Grivel, A. Tomei, A. Rougemont-Bücking. Dépendances – acquisitions thérapeutiques 2010. Revue Médicale Suisse 2011;7:16-9
  • C. Linnman, A. Rougemont-Bücking, J.C. Beucke, T.A. Zeffiro, M.R. Milad. Shock perception and functional networks of immediate fear in human classical conditioning. Behavioral Brain Research, 2011; 221 (1): 237-52
  • A. Rougemont-Bücking, E. Zimmermann. EMDR based treatment of psychotraumatic antecedents in illicit drug abusers: A report of two cases. Swiss Archives of Neurology and Psychiatry; 2012; 163 (3): 107-15
  • K. Lebron-Milad, B. Abbs, M.R Milad, C. Linnman, A. Rougemount-Bücking, M.A. Zeidan, D.J. Holt, J.M. Goldstein. Sex differences in the neurobiology of fear conditioning and extinction: a preliminary fMRI study of shared sex differences with stress-arousal circuitry. Biology of Mood & Anxiety Disorders 2012, 2:7
  • A. Rougemont-Bücking. Trauma et mémoire – Quand la douleur infiltre le corps et l’âme Swiss Archives of Neurology and Psychiatry; 2013; 164 (1): 5-12
  • Book review: A. Rougemont-Bücking. The archaeology of mind – Neuroevolutionary origins of human emotions; authors : Panksepp J, Biven L. Review published in French language in : Revue Francophone de Clinique Comportementale et Cognitive ; 2013, 8 (2) : 57-58
  • A. Rougemont-Bücking, J. Grivel. Risk perception and emotional coping: a pathway for behavioral addiction? European Addiction Research; 2014; 20 (1):49-58
  • J. Besson, J. Grivel, A. Tomei, J.-P. Falcheri, A. Rougemont-Bücking, Y. Khazaal. Addictions. Revue Médicale Suisse 2014; 10:13-17
  • A. Rougemont-Bücking, J.-P. Falcheri, V. Rossier, A. Veron, C. Zumwald, J. Eicher, D. Noetzli, C. Perriard, L. Menneret, F. Rollo, E. Castro, J. Besson. Le traitement orienté en phases en addictologie – un concept intégratif pour la prise en charge de longue durée des patients souffrant de troubles addictifs. Swiss Archives of Neurology and Psychiatry; 2015; 166 (1): 8-16
  • A. Tomei, N. Reber, A. Rougemont-Bücking, J. Besson, J. Grivel. Personal distress and empathic concern in methadone-maintained patients. Journal of Substance Abuse; 2016; 22 (1): 37 - 41
  • Book chapter : A. Rougemont-Bücking. Die Rolle von psychoaktiven Substanzen bei Lern- und Anpassungsprozessen. In: Handbuch Psychoaktive Substanzen; editors: H. Jungaberle, M. Von Heyden; T. Majic. Springer Verlag; 2016, Heidelberg, Berlin.
  • A. Rougemont-Bücking, F. Gamma, J. Panksepp. Use of Tramadol in psychiatry: A comprehensive review and report of two cases. Swiss Medical Weekly; 2017; 147 : w14428
  • G. Gmel, C. Clair, A. Rougemont-Bücking, V.S. Grazioli, J.-B. Daeppen, M. Mohler-Kuo, J. Studer. Snus and snuff use in Switzerland among young men: are there beneficial effects on smoking? Nicotine and Tobacco Research; 2017; 20(11):1301-1309
  • A. Rougemont-Bücking, J. Studer, V. Grazioli, J.-B. Daeppen, G. Gmel. Family-related stress versus external stressors: differential impacts on alcohol and illicit drug use in young men. European Addiction Research; 2017; 23(6):284-297
  • J. Studer, N. Bertholet, S. Baggio, J. Gaume, V.S. Grazioli, A. Rougemont-Bücking, J.-B. Daeppen, G. Gmel. Cigarette and cannabis use in young Swiss men: examination of the bidirectional, longitudinal associations between frequency of use and descriptive norms. Journal of Studies on Alcohol and Drugs; 2018; 79(4):5854-590
  • S. Marmet, J. Studer, A. Rougemont-Bücking, G. Gmel. Latent profiles of family background, personality and mental health factors and their association with behavioural addictions and substance use disorders in young Swiss men. European Psychiatry; 2018; 52:76-84
  • A. Rougemont-Bücking, V. Grazioli, S. Marmet, J.-B. Daeppen, M. Lemoine, G. Gmel, J. Studer. Non-medical use of prescription drugs by young men: impact of potentially traumatic events and of social-environmental stressors. European Journal of Psychotraumatology; 2018; 9(1): 1468706
  • V. S. Grazioli, C. L. Bagge, J. Studer, N. Bertholet, A. Rougemont-Bücking, M. Mohler-Kuo, J.-B. Daeppen, G. Gmel. Depressive symptoms, alcohol use and coping drinking motives: Examining various pathways to suicide attempts among young men. Journal of Affective Disorders; 2018; 232:243-251
  • H. Jungaberle, S. Thal, A. Zeuch, A. Rougemont-Bücking, M. von Heyden, H. Aicher, M. Scheidegger. The investigation of positive personal and social change through psychedelics and entactogens: A systematic review. Neuropharmacology; 2018; pii: S0028-3908(18)30336-8
  • A. Rougemont-Bücking, H. Jungaberle, M. Scheidegger, M.C.G. Merlo, V. S. Grazioli, J.-B. Daeppen, G. Gmel, J. Studer. Comparing mental health across distinct groups of users of psychedelics, MDMA, psychostimulants, and cannabis. Journal of Psychoactive Drugs; 2019; 51(3):236-246
  • V. S. Grazioli, G. Gmel, A. Rougemont-Bücking, S. Baggio, J.-B. Daeppen, J. Studer. Attention deficit hyperactivity disorder and future alcohol outcomes: Examining the roles of coping and enhancement drinking motives among young men. PLoS ONE; 2019 ; 14(6):e0218469
  • A. Rougemont-Bücking, P. Gasser. Psychedelika als Wirkstoff für die Psychotherapie von Traumafolgestörungen und Suchterkrankungen. Suchtmagazin Schweiz; 2020; (3): 12-16